[Federal Register Volume 86, Number 88 (Monday, May 10, 2021)]
[Notices]
[Pages 24867-24868]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09811]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2020-N-2030; FDA-2017-N-4951; FDA-2017-N-5569; FDA-
2020-N-1652; FDA-2017-N-7012; and FDA-2019-N-4763]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approvals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of 
information collections that have

[[Page 24868]]

been approved by the Office of Management and Budget (OMB) under the 
Paperwork Reduction Act of 1995 (PRA).

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-7726, 
[email protected].

SUPPLEMENTARY INFORMATION: The following is a list of FDA information 
collections recently approved by OMB under section 3507 of the PRA (44 
U.S.C. 3507). The OMB control number and expiration date of OMB 
approval for each information collection are shown in table 1. Copies 
of the supporting statements for the information collections are 
available on the internet at https://www.reginfo.gov/public/do/PRAMain. 
An Agency may not conduct or sponsor, and a person is not required to 
respond to, a collection of information unless it displays a currently 
valid OMB control number.

        Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
                                            OMB control    Date approval
           Title of collection                  No.           expires
------------------------------------------------------------------------
Applications for FDA Approval to Market        0910-0001       3/31/2024
 a New Drug.............................
Medical Devices; Humanitarian Use              0910-0332       3/31/2024
 Devices................................
Medical Devices; Device Tracking........       0910-0442       3/31/2024
Dispute Resolution Procedures for              0910-0566       3/31/2024
 Science Based Decision on Products
 Regulated by CVM.......................
Use of Public Human Genetic Variant            0910-0850       3/31/2024
 Databases to Support Clinical Validity
 for Genetic and Genomic-Based In Vitro
 Diagnostics............................
Assessment of Terms and Phrases Commonly       0910-0895       3/31/2024
 Used in Prescription Drug Promotion....
------------------------------------------------------------------------


    Dated: May 4, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-09811 Filed 5-7-21; 8:45 am]
BILLING CODE 4164-01-P